Novo Nordisk A/S ( NYSE:NVO – Get Free Report ) last released its earnings results on Wednesday, August 6th. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The company had revenue of $11.69 billion for the quarter, compared to analysts' expectations of $77.51 billion. Novo Nordisk A/S had a return on equity of 78.64% and a net margin of 35.60%. Analysts forecast that Novo Nordisk A/S will post 3.84 earnings per share for the current year.